Prescient Therapeutics targets rare T-cell cancer in new clinical trial, doses first patient

By Proactive Investors / May 28, 2025 / www.youtube.com / Article Link

Prescient Therapeutics Ltd CEO James McDonnell talked with Proactive about the initiation of a Phase 2A clinical trial for the ...

Recent News

Many new players enter TSXV gold Top 25 by market cap

July 14, 2025 / www.canadianminingreport.com

Gold stocks mixed on moderate metal gain, flat equities

July 14, 2025 / www.canadianminingreport.com

Gold stocks lead the large cap miners by far over H1/25

July 07, 2025 / www.canadianminingreport.com

Gold stocks up as the metal price and equities gain

July 07, 2025 / www.canadianminingreport.com

Mixed outlook for gold as it remains range bound for past three months

June 30, 2025 / www.canadianminingreport.com

See all >